DK1309315T3 - Hurtigt disintegrerende oral valdecoxib-formulering - Google Patents

Hurtigt disintegrerende oral valdecoxib-formulering

Info

Publication number
DK1309315T3
DK1309315T3 DK01964122T DK01964122T DK1309315T3 DK 1309315 T3 DK1309315 T3 DK 1309315T3 DK 01964122 T DK01964122 T DK 01964122T DK 01964122 T DK01964122 T DK 01964122T DK 1309315 T3 DK1309315 T3 DK 1309315T3
Authority
DK
Denmark
Prior art keywords
molded article
rapidly disintegrating
oral cavity
disintegrating oral
cyclooxygenase
Prior art date
Application number
DK01964122T
Other languages
English (en)
Inventor
Tugrul T Kararli
Trang T Le
Mark J Kontny
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Application granted granted Critical
Publication of DK1309315T3 publication Critical patent/DK1309315T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrane Compounds (AREA)
DK01964122T 2000-08-18 2001-08-17 Hurtigt disintegrerende oral valdecoxib-formulering DK1309315T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22648700P 2000-08-18 2000-08-18

Publications (1)

Publication Number Publication Date
DK1309315T3 true DK1309315T3 (da) 2006-10-09

Family

ID=22849097

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01964122T DK1309315T3 (da) 2000-08-18 2001-08-17 Hurtigt disintegrerende oral valdecoxib-formulering

Country Status (14)

Country Link
US (1) US20020071857A1 (da)
EP (1) EP1309315B1 (da)
JP (1) JP2004506680A (da)
AT (1) ATE329583T1 (da)
AU (1) AU2001285011A1 (da)
CA (1) CA2419592A1 (da)
CY (1) CY1105319T1 (da)
DE (1) DE60120710T2 (da)
DK (1) DK1309315T3 (da)
ES (1) ES2265439T3 (da)
MX (1) MXPA03001407A (da)
NZ (1) NZ524124A (da)
PT (1) PT1309315E (da)
WO (1) WO2002015884A2 (da)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040044990A (ko) * 2001-09-26 2004-05-31 파마시아 코포레이션 구강내 붕해성 발데콕시브 조성물
CN1602187A (zh) * 2001-10-10 2005-03-30 法马西亚公司 通过喷雾干燥法制备的口内崩解的伐地考昔组合物
WO2003049720A1 (en) * 2001-12-07 2003-06-19 Merck & Co., Inc. Combination therapy comprising a cyclooygenase-2 inhibitor
US7927613B2 (en) * 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
US7790905B2 (en) * 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
WO2003074474A2 (en) * 2002-03-01 2003-09-12 University Of South Florida Multiple-component solid phases containing at least one active pharmaceutical ingredient
WO2004026235A2 (en) * 2002-09-20 2004-04-01 Transform Pharmaceuticals, Inc. Pharmaceutical compositions with improved dissolution
CN100360117C (zh) * 2002-06-21 2008-01-09 转化医药公司 具有提高的溶出度的药物组合物
US8183290B2 (en) 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
CN1819819B (zh) * 2003-05-07 2011-03-09 株式会社三养社 用于制备速熔片的高度可塑性颗粒
BRPI0302736B8 (pt) * 2003-06-02 2021-05-25 Ems S/A composição farmacêutica a base de cetorolaco ou de um de seus sais farmaceuticamente aceitáveis para uso sublingual
US20050113410A1 (en) * 2003-11-03 2005-05-26 Mark Tawa Pharmaceutical salts of zafirlukast
EP1832288B1 (en) * 2004-12-27 2012-06-20 Astellas Pharma Inc. Stable granular pharmaceutical composition of solifenacin or its salt
GB2423710A (en) 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
CN101132779B (zh) * 2005-03-07 2016-03-16 拜尔健康护理有限责任公司 用于治疗癌症的包含ω-羧芳基取代的二苯基脲的药物组合物
EP1793801A1 (en) * 2005-07-15 2007-06-13 Teva Pharmaceutical Industries Ltd. Novel granulation process and granulate produced therefrom
US8252328B2 (en) * 2006-01-06 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US8535714B2 (en) 2006-01-06 2013-09-17 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8252329B2 (en) * 2007-01-05 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US8865743B2 (en) * 2006-01-06 2014-10-21 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US9289583B2 (en) 2006-01-06 2016-03-22 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8357114B2 (en) 2006-01-06 2013-01-22 Acelrx Pharmaceuticals, Inc. Drug dispensing device with flexible push rod
US8202535B2 (en) 2006-01-06 2012-06-19 Acelrx Pharmaceuticals, Inc. Small-volume oral transmucosal dosage forms
US8753308B2 (en) 2006-01-06 2014-06-17 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US9066847B2 (en) 2007-01-05 2015-06-30 Aceirx Pharmaceuticals, Inc. Storage and dispensing devices for administration of oral transmucosal dosage forms
KR101606944B1 (ko) * 2007-08-07 2016-03-28 아셀알엑스 파마슈티컬스 인코퍼레이티드 경구 경점막 투여형을 사용한 시술시 진정과 무통을 위한 조성물 및 방법
WO2009063367A1 (en) * 2007-11-15 2009-05-22 Pfizer Products Inc. Dosage forms comprising celecoxib providing both rapid and sustained pain relief
BRPI0822655A2 (pt) 2008-06-04 2015-06-30 Colgate Palmolive Co Implemento e sistema para cuidado oral
US20100075930A1 (en) * 2008-09-03 2010-03-25 Yoel Ovil Salicylic salt compositions and related method of treatment of cardiac conditions
US8945592B2 (en) 2008-11-21 2015-02-03 Acelrx Pharmaceuticals, Inc. Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
US10420665B2 (en) 2010-06-13 2019-09-24 W. L. Gore & Associates, Inc. Intragastric device for treating obesity
US10010439B2 (en) 2010-06-13 2018-07-03 Synerz Medical, Inc. Intragastric device for treating obesity
US9526648B2 (en) 2010-06-13 2016-12-27 Synerz Medical, Inc. Intragastric device for treating obesity
US8628554B2 (en) 2010-06-13 2014-01-14 Virender K. Sharma Intragastric device for treating obesity
KR20150056586A (ko) * 2012-09-13 2015-05-26 씨비에이 파마, 인크. 테트란드린 제약 제제 및 방법
AU2015369710B2 (en) 2014-12-23 2020-09-17 Vertical Pharmaceuticals, Llc Systems, devices and methods for dispensing oral transmucosal dosage forms
US10779980B2 (en) 2016-04-27 2020-09-22 Synerz Medical, Inc. Intragastric device for treating obesity
US10350171B2 (en) 2017-07-06 2019-07-16 Dexcel Ltd. Celecoxib and amlodipine formulation and method of making the same
EP3740284A4 (en) * 2018-01-21 2021-10-13 Kastner, Bernie D. PREPARATION AND METHOD FOR TREATMENT OF MIGRAINE

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation
HU219349B (en) * 1991-12-24 2001-03-28 Yamanouchi Pharma Co Ltd Intrabuccally disintegrating preparation and production thereof
DE69331839T2 (de) * 1992-01-29 2002-12-12 Takeda Chemical Industries Ltd Schnellösliche Tablette und ihre Herstellung
US5567439A (en) * 1994-06-14 1996-10-22 Fuisz Technologies Ltd. Delivery of controlled-release systems(s)
CA2178686A1 (en) * 1995-06-13 1996-12-14 Leslie G. Humber Oral formulations of s(+)-etodolac
CN1140267C (zh) * 1996-05-17 2004-03-03 麦克公司 治疗环加氧酶-2介导的疾病的每天一次的组合物
IT1293764B1 (it) * 1997-07-23 1999-03-10 Chiesi Farma Spa Composizioni farmaceutiche sotto forma di compresse effervescenti contenenti un principio attivo instabile in presenza di acqua
IT1298732B1 (it) * 1998-03-13 2000-02-02 Recordati Chem Pharm Composizioni farmaceutiche orali assumibili senza liquidi,contenenti complessi di inclusione
JP2002529406A (ja) * 1998-11-12 2002-09-10 メルク エンド カムパニー インコーポレーテッド ＧＡＢＡＡα５逆活性薬と、ＣＯＸ−２阻害剤、ＮＳＡＩＤ、エストロゲン、又はビタミンＥとの組合わせ
SA99191255B1 (ar) * 1998-11-30 2006-11-25 جي دي سيرل اند كو مركبات سيليكوكسيب celecoxib
CZ300615B6 (cs) * 1999-11-30 2009-07-01 Panacea Biotec Limited Rychle rozpustný farmaceutický prostredek v pevné dávkové forme s prodlouženou sladkou chutí a zpusob jeho prípravy

Also Published As

Publication number Publication date
PT1309315E (pt) 2006-09-29
NZ524124A (en) 2004-09-24
DE60120710D1 (de) 2006-07-27
DE60120710T2 (de) 2007-06-14
AU2001285011A1 (en) 2002-03-04
CY1105319T1 (el) 2010-03-03
US20020071857A1 (en) 2002-06-13
ATE329583T1 (de) 2006-07-15
WO2002015884A2 (en) 2002-02-28
EP1309315A2 (en) 2003-05-14
WO2002015884A3 (en) 2002-07-25
MXPA03001407A (es) 2003-06-06
EP1309315B1 (en) 2006-06-14
ES2265439T3 (es) 2007-02-16
JP2004506680A (ja) 2004-03-04
CA2419592A1 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
DK1309315T3 (da) Hurtigt disintegrerende oral valdecoxib-formulering
EP1120109A3 (en) Rapidly disintegrating and fast dissolving solid dosage form
NO20070887L (no) Kornformet farmasoytisk preparat med tidsbegrenset frigivelse for oral administrasjon, og intraoral hurtig desintegrerende tablett som inneholder preparatet
NZ734446A (en) Pharmaceutical formulations of bruton’s tyrosine kinase inhibtor
MX9308188A (es) Glucomanano de konjac facilmente disponible, como un excipiente de liberacion sostenida.
ATE336232T1 (de) Arzneiform und verfahren ihrer herstellung
HUP0101517A2 (hu) Efavirenz hatóanyagot tartalmazó, gyorsan oldódó kapszulák és tabletták, valamint eljárás ezek előállítására
CO5170471A1 (es) Tabletas de liberacion modificada que incluyen amoxilina y clavulanato de potasio
RS52374B (en) FORMS OF MEDICINES WITH IMPROVED PHARMACOKINETIC CHARACTERISTICS
MY128368A (en) Method for producing quickly decomposable solid pharmaceutical preparations
CY1107465T1 (el) Μελαγατρανη για τη θepαπευτικη αντιμετωπιση φλεγμονων
WO2008142572A3 (en) Controlled release tablet formulation containing magnesium aluminometasilicate
BR0013106A (pt) Composição farmacêutica flutuante, comprimido, e processo de prepapação de um comprimido.
NO20034417L (no) Engangs vaginalkanyle for samtidig administrasjon av medikamenter i ulike former
ATE266404T1 (de) Eine stabile pharmazeutische formulierung die torsemid modifikation ii enthält
WO2010019279A8 (en) Pharmaceutical compositions configured to deter dosage form splitting
Pandey et al. Orodispersible tablets-a review
DE69830176D1 (de) Arzneimittel gegen infertilität, die mit endometriose assoziiert ist
CO5160319A1 (es) Formulaciones de liberacion controlada de metamizol
DE60123447D1 (de) Arzneimittel mit verzögerter wirkstoffabgabe
PT1499278E (pt) Forma de dosagem farmaceutica de libertacao imediata compreendendo tibolona polimorfa
CN105581991A (zh) 一种酒石酸唑吡坦舌下片及其制备方法
Han et al. Mycosis fungoides responsive to oral alitretinoin and ultraviolet B phototherapy: A case report
KR20180049753A (ko) 염증성 부종 및 발열·통증을 동반한 상기도 감염을 치료하는 양·한방 융복합 삼중정 치료제
ECSP993186A (es) Formulaciones de liberacion controlada de metamizol